BNY Mellon Smart Cures Innovation Fund USD A Acc Fonds Kurs - 1 Jahr
Fundamentaldaten
| Valor | 59015949 |
| ISIN | IE00BLB0VD50 |
| Name | BNY Mellon Smart Cures Innovation Fund USD A Acc Fonds |
| Fondsgesellschaft | BNY Mellon Fund Management |
| Aufgelegt in | Ireland |
| Auflagedatum | 14.12.2020 |
| Kategorie | Branchen: Gesundheitswesen |
| Währung | USD |
| Volumen | 18’498’223.75 |
| Depotbank | Bank of New York Mellon SA/NV, Dublin Branch |
| Zahlstelle | |
| Fondsmanager | Edward Walter, Matthew Jenkin |
| Geschäftsjahresende | 31.12. |
| Berichtsstand | 19.12.2023 |
Anlagepolitik
So investiert der BNY Mellon Smart Cures Innovation Fund USD A Acc Fonds: The Sub-Fund aims to achieve long-term capital growth and has a sustainable investment objective. Specifically, the Sub-Fund aims to contribute to a social objective by investing in securities of companies located worldwide that improve the adequacy and efficiency of health systems through innovation in biotechnology and healthcare.